Co-Diagnostics, Inc.
(NASDAQ : CODX)

( )
CODX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -3.84%70.101.0%$1236.81m
BIIBBiogen, Inc. -0.57%324.111.5%$646.07m
AMGNAmgen, Inc. -3.44%210.381.3%$518.31m
REGNRegeneron Pharmaceuticals, Inc. 3.99%442.352.6%$477.18m
ILMNIllumina, Inc. -3.97%269.953.5%$388.79m
VRTXVertex Pharmaceuticals, Inc. -2.96%230.001.9%$337.69m
ALXNAlexion Pharmaceuticals, Inc. -2.91%96.142.0%$219.25m
MRNAModerna, Inc. 27.81%23.760.0%$199.48m
AAgilent Technologies, Inc. -3.22%77.911.6%$163.21m
EXASEXACT Sciences Corp. -9.44%86.5424.0%$149.73m
INCYIncyte Corp. -1.97%77.322.5%$112.54m
BMRNBioMarin Pharmaceutical, Inc. -2.15%91.004.3%$106.32m
SGENSeattle Genetics, Inc. -3.12%112.386.1%$105.27m
XLRNAcceleron Pharma, Inc. -2.23%88.196.1%$84.80m
ALNYAlnylam Pharmaceuticals, Inc. -2.45%119.298.7%$81.58m

Company Profile

Co-Diagnostics, Inc. is a molecular diagnostics company, which engages in the development, manufacture, and marketing of diagnostics technology. The company's products are utilized for tests that are designed using the detection and analysis of nucleic acid molecules. It also uses its proprietary technology to design tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.